Hims & Hers Health (NYSE: HIMS) stock surged 23% on Tuesday, April 29, after Novo Nordisk announced plans to offer popular ...

Hims & Hers boasts excellent underlying performance, but the stock's current valuation remains uncomfortably high. Despite a 40% drop in stock price, shares are not yet a value, and selling put ...

Throughout the last three months, 13 analysts have evaluated Hims & Hers Health HIMS, offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments, the table ...

Citi lowered the firm’s price target on Hims & Hers to $25 from $27 and keeps a Sell rating on the shares. The firm also added a “downside 30-day short-term view” on the shares. Citi expects ...

Shares of Hims & Hers Health stock opened at $28.10 on Friday. Hims & Hers Health has a 12-month low of $11.20 and a 12-month high of $72.98. The stock has a market capitalization of $6.24 billion ...

In the latest market close, Hims & Hers Health, Inc. (HIMS) reached $28.10, with a -0.14% movement compared to the previous day. This change lagged the S&P 500's daily gain of 0.74%. Elsewhere ...

His infamous sketch in the back of a yellow cab became the most imitated logo in history—and cities are still copying it today. In the summer of 1977, New York City was burning. A 25-hour ...

In the latest market close, Hims & Hers Health, Inc. (HIMS) reached $28.10, with a -0.14% movement compared to the previous day. This change lagged the S&P 500's daily gain of 0.74%. Elsewhere, the ...

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our Small-Cap Growth Investor model based on the ...